by Jen Hodson | Feb 14, 2019 | Press Releases
Findings to be presented at the 2019 American Society of Clinical Oncology’s Genitourinary Cancers Symposium San Francisco and Culver City, CA – February 14, 2019 – Scientific teams from NantHealth (NASDAQ: NH) and NantOmics will present two posters at the American...
by Jen Hodson | Feb 12, 2019 | Events, Press Releases
Collaboration with Leading Kidney Care Vendors, Intelligent Health and Connected Care Showcased Culver City, CA and Orlando, FL — February 12, 2019 – NantHealth, Inc. (NASDAQ: NH), a leader in connected care solutions, will unveil a series of new initiatives...
by Jen Hodson | Feb 11, 2019 | Press Releases
NantHealth has validated successful DeviceConX™ integration with Baxter’s Prismaflex system, used to treat critically-ill patients in the ICU Connectivity is being used in multiple U.S. hospitals Baxter and NantHealth are also working on Baxter’s next generation...
by Jen Hodson | Jan 4, 2019 | Press Releases
Immunotherapy Company Will Present Findings at the JP Morgan Healthcare Conference in San Francisco on January 7th Second Round Crossover Funding Brings Celgene’s Investment to $105M in NantCell Valued at $4 Billion Currently Enrolling Patients in Advanced Stage...
by Jen Hodson | Dec 3, 2018 | Press Releases
Topics to include DNA and RNA profiling and next-generation sequencing of tumors San Antonio, TX – Dec 3, 2018 – Significant developments in breast cancer research will be presented by NantHealth (NASDAQ: NH) at the San Antonio Breast Cancer Symposium this week....
